生検針市場：タイプ,手技,分類,材質,購入チャネル,用途,エンドユーザー別-2025-2030年世界予測

生検針市場は、2024年には7億3,549万米ドルとなり、2025年には7億7,771万米ドル、CAGR 5.81%で成長し、2030年には10億3,273万米ドルに達すると予測されています。

目まぐるしく変化する今日の医療機器市場において、生検針の世界は、先端技術、臨床転帰の改善、低侵襲手技の重視の高まりに後押しされ、大きな変貌を遂げつつあります。生検針市場は、新たな動向や患者のニーズの変化に対応するため、業界のリーダーやヘルスケア専門家の注目を集めています。本レポートでは、これらの重要な診断ツールの性能と採用を形成している市場力学、主要な技術革新、進化する規制の枠組みについて詳しく見ていきます。

材料科学と精密工学における最近の進歩により、メーカーはより効率的であるだけでなく、より安全で費用対効果の高い針を製造できるようになりました。乳房生検から前立腺生検に至るまで、様々な用途における早期診断手技に対する需要の高まりは、デザイン、機能性、全体的性能の継続的改善に拍車をかけています。さらに、価値観に基づくヘルスケアと治療経路におけるコスト最適化の世界の推進により、品質、患者アウトカム、経済性が微妙にバランスをとる競合情勢となっています。

本サマリーは、生検針市場の包括的な概観を提供し、変化を促す要因にスポットを当て、セグメンテーション戦略を調整し、地域差と競争イノベーションを図解します。本レポートは、詳細な分析と厳密なデータインサイトを通じて、あらゆるレベルの利害関係者が情報に基づいた意思決定を行えるようにすることを目的としています。

生検針市場における変革的変化

生検針市場は、ヘルスケアプロバイダーが診断介入に取り組む方法を再構築する変革的なシフトを目の当たりにしています。特に針のデザイン、画像統合、患者の安全性の分野において、技術の飛躍的進歩がこの進化の最前線にあります。技術革新は、組織サンプリングの改善、患者の不快感の最小化、手技効率の向上を提供する針の開発につながりました。これらの技術革新が従来の方法を破壊し続ける中、メーカーは生検針のデザインと機能の両方をさらに最適化するための研究開発に投資しています。

明確な変化のひとつは、デジタル画像とロボット支援機能の統合であり、これは針の設置精度を向上させるだけでなく、手技の合理化にもつながっています。競争の激化に伴い、各社は現在、複雑な手技の学習曲線を短縮し、医師が使用するたびに一貫した結果を得られるようにすることに注力しています。これと相まって、カスタマイズと製品の多様化が重視され、さまざまな臨床環境の多様な要求に対応できるように機器が調整されています。

市場の経験も、滅菌と持続可能性への重点の高まりとともに進化しており、これは世界のヘルスケアにおけるより広範な動向を反映した変化です。ヘルスケア施設はこうした変化に対応するため、卓越したエンジニアリングと最新の製造技術の効率性を兼ね備えた製品を求めるようになっています。このような品質とイノベーションへの包括的な焦点は、生検針の競合情勢に新たなベンチマークを設定しつつあります。

主要セグメント分析

生検針市場を詳細に解剖すると、多面的なセグメンテーション戦略が明らかになり、市場動向と潜在的成長ベクトルに関する重要な洞察が得られます。1つの側面は針のタイプに焦点を当て、Monopty NeedleやTemno Needleなど、それぞれ特定の臨床要件に適合するように微妙な違いをもって設計された器具を対象として市場を調査します。もう一つのセグメンテーションは手技に基づくもので、吸引生検、コア生検、真空補助下生検を含み、臨床応用と手技の多様性を強調しています。分析ではさらに、器具のカテゴリーを考慮し、コスト管理と患者の安全性の双方にとって重要な要素である使い捨て針と再利用可能針の利点と課題を評価しています。さらに、素材構成は不可欠なパラメータであり、金属製の器具とプラスチック製の器具によって市場が差別化され、それぞれが耐久性と性能の面で独自の利点を提供しています。

また、購買チャネルに基づく細分化された見解からも洞察が浮かび上がります。この市場は、オフライン販売とオンライン販売の両プラットフォームによって綿密に調査されており、現代の調達戦略の二面性を反映しています。さらに、乳房、腎臓、肝臓、肺、前立腺生検の診断手技を含むアプリケーションベースのセグメンテーションにより、さまざまな臨床専門分野にわたる需要を詳細に把握することができます。最後に、外来手術センター、診断クリニック、病院における生検針の使用を分析するエンドユーザーセグメンテーションでは、医療機関の購買動向と使用パターンを包括的に把握することができます。これらのセグメンテーションの洞察は、市場セグメンテーションの分析フレームワークのバックボーンを形成し、市場参入企業が製品開拓とマーケティング戦略を顧客ニーズの新興市場に適合させるための指針となります。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • がんや慢性疾患の世界の発生率の増加
    • 患者の間で低侵襲手術への関心が高まっている
    • ヘルスケアインフラを世界規模で拡大
  • 抑制要因
    • 厳格な規制承認とコンプライアンス要件
  • 機会
    • 生検針の生分解性材料における継続的なイノベーション
    • 診断精度向上のため、リアルタイム組織分析が可能なスマート生検針を開発
  • 課題
    • 製品品質の一貫性の問題
• 市場セグメンテーション分析
  • タイプ：精度と使いやすさからモノプティ針の採用が増加
  • エンドユーザー：病院における生検針の活用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 生検針市場：タイプ別

• モノプティ針
• テムノニードル

第7章 生検針市場手順別

• 吸引生検
• コア生検
• 吸引補助生検

第8章 生検針市場：カテゴリ別

• 使い捨て
• 再利用可能

第9章 生検針市場：素材別

• 金属
• プラスチック

第10章 生検針市場購入チャネル別

• オフライン販売
• オンライン販売

第11章 生検針市場：用途別

• 乳房生検
• 腎生検
• 肝生検
• 肺生検
• 前立腺生検

第12章 生検針市場：エンドユーザー別

• 外来手術センター
• 診断クリニック
• 病院

第13章 南北アメリカの生検針市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第14章 アジア太平洋地域の生検針市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第15章 欧州・中東・アフリカの生検針市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第16章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Argon Medical Devices, Inc.
• B. Braun SE
• Becton, Dickinson and Company
• Biomedical Srl
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cook Group Incorporated
• Doctor Japan Co., Ltd.
• Freudenberg Medical, LLC
• Geotek Medical
• Hologic, Inc.
• Inrad, Inc.
• IZI Medical Products
• Medax Srl
• Medi-Tech Devices Pvt. Ltd.
• Medtronic PLC
• Merit Medical Systems, Inc.
• Mermaid Medical Group
• Olympus Corporation
• Pajunk GmbH Medizintechnologie
• Point Blank Medical
• Remington Medical
• Stryker Corporation
• Volkmann MedizinTechnik GmbH
• weLLgo Medical Products GmbH

LIST OF FIGURES

• FIGURE 1. BIOPSY NEEDLES MARKET MULTI-CURRENCY
• FIGURE 2. BIOPSY NEEDLES MARKET MULTI-LANGUAGE
• FIGURE 3. BIOPSY NEEDLES MARKET RESEARCH PROCESS
• FIGURE 4. BIOPSY NEEDLES MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL BIOPSY NEEDLES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 19. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 21. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 25. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 27. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 28. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 29. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 30. BIOPSY NEEDLES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 31. BIOPSY NEEDLES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. BIOPSY NEEDLES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL BIOPSY NEEDLES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOPSY NEEDLES MARKET DYNAMICS
• TABLE 7. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MONOPTY NEEDLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TEMNO NEEDLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ASPIRATION BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CORE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY METAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PLASTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY OFFLINE SALES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LIVER BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. CANADA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. CANADA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 57. CANADA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 58. CANADA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 59. CANADA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 60. CANADA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. CANADA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. CHINA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. CHINA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 94. CHINA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 95. CHINA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 96. CHINA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. CHINA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. CHINA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. INDIA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. INDIA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 101. INDIA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 102. INDIA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 103. INDIA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. INDIA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. INDIA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. INDONESIA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. INDONESIA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 108. INDONESIA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. JAPAN BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. JAPAN BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 115. JAPAN BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. MALAYSIA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. MALAYSIA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 122. MALAYSIA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. PHILIPPINES BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. PHILIPPINES BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 129. PHILIPPINES BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. SINGAPORE BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SINGAPORE BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 136. SINGAPORE BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. SOUTH KOREA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. SOUTH KOREA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 143. SOUTH KOREA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 148. TAIWAN BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. TAIWAN BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 150. TAIWAN BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 155. THAILAND BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. THAILAND BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 157. THAILAND BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. VIETNAM BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 163. VIETNAM BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 164. VIETNAM BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 169. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 177. DENMARK BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 178. DENMARK BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 179. DENMARK BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 184. EGYPT BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. EGYPT BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 186. EGYPT BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 191. FINLAND BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. FINLAND BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 193. FINLAND BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 198. FRANCE BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 199. FRANCE BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 200. FRANCE BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 205. GERMANY BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 206. GERMANY BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 207. GERMANY BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 212. ISRAEL BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 213. ISRAEL BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 214. ISRAEL BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 219. ITALY BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 220. ITALY BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 221. ITALY BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 222. ITALY BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 223. ITALY BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 224. ITALY BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. ITALY BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 226. NETHERLANDS BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 227. NETHERLANDS BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 228. NETHERLANDS BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 233. NIGERIA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 234. NIGERIA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 235. NIGERIA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 236. NIGERIA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 240. NORWAY BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 241. NORWAY BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 242. NORWAY BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 243. NORWAY BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 247. POLAND BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 248. POLAND BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 249. POLAND BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 250. POLAND BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 251. POLAND BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 252. POLAND BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 253. POLAND BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 254. QATAR BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 255. QATAR BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 256. QATAR BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 257. QATAR BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 258. QATAR BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 259. QATAR BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 260. QATAR BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 261. RUSSIA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 262. RUSSIA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 263. RUSSIA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 264. RUSSIA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 268. SAUDI ARABIA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 269. SAUDI ARABIA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 270. SAUDI ARABIA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 271. SAUDI ARABIA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 275. SOUTH AFRICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 276. SOUTH AFRICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 277. SOUTH AFRICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 278. SOUTH AFRICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH AFRICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 282. SPAIN BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 283. SPAIN BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 284. SPAIN BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 285. SPAIN BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 288. SPAIN BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 289. SWEDEN BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 290. SWEDEN BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 291. SWEDEN BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 292. SWEDEN BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 295. SWEDEN BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 296. SWITZERLAND BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 297. SWITZERLAND BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 298. SWITZERLAND BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 299. SWITZERLAND BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 302. SWITZERLAND BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 303. TURKEY BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 304. TURKEY BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 305. TURKEY BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 306. TURKEY BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 307. TURKEY BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 308. TURKEY BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 309. TURKEY BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 310. UNITED ARAB EMIRATES BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 311. UNITED ARAB EMIRATES BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 312. UNITED ARAB EMIRATES BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 313. UNITED ARAB EMIRATES BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 314. UNITED ARAB EMIRATES BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 315. UNITED ARAB EMIRATES BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 316. UNITED ARAB EMIRATES BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 317. UNITED KINGDOM BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 318. UNITED KINGDOM BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 319. UNITED KINGDOM BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 320. UNITED KINGDOM BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 321. UNITED KINGDOM BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
• TABLE 322. UNITED KINGDOM BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 323. UNITED KINGDOM BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 324. BIOPSY NEEDLES MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 325. BIOPSY NEEDLES MARKET, FPNV POSITIONING MATRIX, 2024

The Biopsy Needles Market was valued at USD 735.49 million in 2024 and is projected to grow to USD 777.71 million in 2025, with a CAGR of 5.81%, reaching USD 1,032.73 million by 2030.

In today's fast-paced medical device market, the world of biopsy needles is undergoing a significant transformation driven by advanced technologies, improved clinical outcomes, and a growing emphasis on minimally invasive procedures. The biopsy needles market has garnered the attention of industry leaders and healthcare professionals alike as it adapts to emerging trends and shifting patient needs. This report sets the stage with an in-depth look at the market dynamics, key innovations, and evolving regulatory frameworks that are shaping the performance and adoption of these critical diagnostic tools.

Recent advancements in material science and precision engineering have enabled manufacturers to produce needles that are not only more efficient but also safer and more cost-effective. The increasing demand for early diagnostic procedures across various applications-from breast to prostate biopsies-has spurred continuous improvement in design, functionality, and overall performance. Furthermore, the global push towards value-based healthcare and cost optimization in treatment pathways has resulted in a competitive landscape where quality, patient outcomes, and economic considerations balance delicately.

This summary provides a comprehensive overview of the biopsy needles market, spotlighting the factors driving change, tailoring segmentation strategies, and illustrating regional variances and competitive innovations. Through detailed analysis and rigorous data insights, this report aims to foster informed decision-making among stakeholders at all levels.

Transformative Shifts in the Biopsy Needles Market

The biopsy needles market is witnessing transformative shifts that are reshaping the way healthcare providers approach diagnostic interventions. Technological breakthroughs are at the forefront of this evolution, particularly in the areas of needle design, imaging integration, and patient safety. Innovations have led to the development of needles that offer improved tissue sampling, minimized patient discomfort, and enhanced procedural efficiency. As these innovations continue to disrupt traditional methods, manufacturers are investing in research and development to further optimize both the design and functionality of biopsy needles.

One clear shift is the integration of digital imaging and robotic assistance, which not only improves the accuracy of needle placement but also streamlines procedures. With rising competition, companies are now focusing on reducing the learning curve for complex procedures, ensuring that practitioners can achieve consistent outcomes with each use. Coupled with this is the emphasis on customization and product diversification, where devices are tailored to meet the varied demands of different clinical environments.

The market experience is also evolving with an increased focus on sterilization and sustainability, a shift that mirrors broader trends in global healthcare. As healthcare facilities adapt to these changes, they are now demanding products that combine excellence in engineering with the efficiency of modern manufacturing techniques. Such a comprehensive focus on quality and innovation is setting a new benchmark in the competitive landscape of biopsy needles.

Key Segmentation Insights

A detailed dissection of the biopsy needles market reveals a multi-faceted segmentation strategy that provides crucial insights into market behavior and potential growth vectors. One dimension focuses on the type of needle, where the market is studied across instruments such as the Monopty Needle and the Temno Needle, each designed with nuanced differences to suit specific clinical requirements. Another layer of segmentation is based on procedure, encompassing Aspiration Biopsy, Core Biopsy, and Vacuum-Assisted Biopsy, which underscores the diversity in clinical applications and procedural techniques. The analysis further considers the category of devices, evaluating the merits and challenges of disposable versus reusable needles, an important factor for both cost management and patient safety. Additionally, material composition is an essential parameter, with the market differentiated by devices made from metal and those crafted from plastic, each offering unique benefits in terms of durability and performance.

Insights also emerge from the segmented view based on purchasing channels. The market is meticulously studied by both offline sales and online sales platforms, reflecting the dual nature of modern procurement strategies. Moreover, application-based segmentation, which includes diagnostic procedures for breast, kidney, liver, lung, and prostate biopsies, provides a granular understanding of demand across various clinical specialties. Finally, the end user segmentation, which analyzes the use of biopsy needles in ambulatory surgical centers, diagnostic clinics, and hospitals, offers a comprehensive view of institutional purchasing trends and usage patterns. These segmentation insights form the backbone of an analytical framework that guides market players in aligning their product development and marketing strategies with evolving customer needs.

Based on Type, market is studied across Monopty Needle and Temno Needle.

Based on Procedure, market is studied across Aspiration Biopsy, Core Biopsy, and Vacuum-Assisted Biopsy.

Based on Category, market is studied across Disposable and Reusable.

Based on Material, market is studied across Metal and Plastic.

Based on Purchasing Channel, market is studied across Offline Sales and Online Sales.

Based on Application, market is studied across Breast Biopsy, Kidney Biopsy, Liver Biopsy, Lung Biopsy, and Prostate Biopsy.

Based on End User, market is studied across Ambulatory Surgical Centers, Diagnostic Clinics, and Hospitals.

Key Regional Insights in Biopsy Needles

Regional dynamics play a pivotal role in the evolution of the biopsy needles market, with distinct trends observable across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, the integration of advanced diagnostic technologies and stringent regulatory standards is driving an accelerated adoption of innovative biopsy needles. This region benefits from a well-established healthcare infrastructure that supports rapid technological assimilation and continuous product improvements.

Shifts in market trends are also evident across Europe, the Middle East, and Africa, where a blend of mature healthcare systems and emerging markets contributes to a diverse range of adoption rates. The region is characterized by a unique interplay between innovation-led advancements and cost-conscious procurement practices, which in turn influence the demand for both disposable and reusable needle variants. Meanwhile, in Asia-Pacific, economic growth coupled with increasing healthcare expenditure is fueling market expansion. This region is emerging as a key hotspot due to enhanced healthcare awareness, government initiatives promoting early disease detection, and growing investments in modern healthcare infrastructure. Together, these regional insights underscore the significance of localized strategies and tailored product offerings that address specific consumer needs and economic conditions in different parts of the world.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Company Insights and Strategic Innovators

The competitive landscape of the biopsy needles market is marked by a constellation of companies that are driving innovation and setting new standards in clinical excellence. Prominent players in this segment include notable organizations such as Argon Medical Devices, Inc., B. Braun SE, and Becton, Dickinson and Company, which have been at the forefront of research and product development. These leading firms are complemented by key industry innovators such as Biomedical Srl and Boston Scientific Corporation, who continue to expand their product portfolios with state-of-the-art technologies.

Other influential names, including Cardinal Health, Inc. and Cook Group Incorporated, have built robust networks that facilitate seamless access to advanced diagnostic tools. The global impact is further strengthened by companies like Doctor Japan Co., Ltd. and Freudenberg Medical, LLC, which ensure excellence in both product quality and customer service. The market is equally shaped by the efforts of Geotek Medical and Hologic, Inc., along with specialized firms such as Inrad, Inc. and IZI Medical Products that deliver targeted solutions for distinct clinical needs.

Additional strategic insights come from players like Medax Srl, Medi-Tech Devices Pvt. Ltd., Medtronic PLC, and Merit Medical Systems, Inc., each contributing to the continuous evolution of product features and functional enhancements. The competitive spirit is evident with innovations from Mermaid Medical Group, Olympus Corporation, and Pajunk GmbH Medizintechnologie, all of which consistently push the boundaries in diagnostic precision. The list of front-running entities is rounded out by contributions from Point Blank Medical, Remington Medical, Stryker Corporation, Volkmann MedizinTechnik GmbH, and weLLgo Medical Products GmbH, whose strategic initiatives collectively redefine market standards and foster sustained industry growth.

The report delves into recent significant developments in the Biopsy Needles Market, highlighting leading vendors and their innovative profiles. These include Argon Medical Devices, Inc., B. Braun SE, Becton, Dickinson and Company, Biomedical Srl, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Doctor Japan Co., Ltd., Freudenberg Medical, LLC, Geotek Medical, Hologic, Inc., Inrad, Inc., IZI Medical Products, Medax Srl, Medi-Tech Devices Pvt. Ltd., Medtronic PLC, Merit Medical Systems, Inc., Mermaid Medical Group, Olympus Corporation, Pajunk GmbH Medizintechnologie, Point Blank Medical, Remington Medical, Stryker Corporation, Volkmann MedizinTechnik GmbH, and weLLgo Medical Products GmbH. Actionable Recommendations for Industry Leaders

Industry leaders are encouraged to leverage current market trends by adopting strategies that prioritize innovation, process efficiency, and end-user satisfaction. It is imperative to invest in research and development programs that not only enhance the precision engineering of biopsy needles but also integrate emerging technologies such as digital imaging and robotics for improved clinical outcomes. A targeted approach to customization across varied clinical applications such as breast, kidney, liver, lung, and prostate biopsies can significantly strengthen market position and meet diverse practitioner needs.

Leaders should also explore opportunities to expand their market footprint by optimizing production processes and streamlining supply chains. Prioritizing sustainable and cost-effective manufacturing practices, especially in the production of both disposable and reusable instruments, can result in improved profitability without sacrificing quality. By aligning product portfolios with evolving regulatory requirements and localized market needs across regions like the Americas, Europe, Middle East & Africa, and Asia-Pacific, companies will be well positioned to capitalize on emerging growth opportunities.

Furthermore, adopting a dual-channel sales strategy that balances traditional offline sales with burgeoning online platforms will enhance customer reach and ensure greater accessibility. Collaborations with leading healthcare institutions to foster clinical partnerships and pilot advanced product trials can also serve as a catalyst for market penetration. Industry executives must continuously monitor technology trends and regulatory updates, enabling proactive adjustments in product development and marketing strategies. With these actionable recommendations, stakeholders can not only secure their market presence but also drive long-term industry transformation.

Conclusion: Strategic Focus for Expanding Market Trajectories

In summary, the biopsy needles market is at the nexus of several key transformative trends that are reshaping industry expectations and defining the future of diagnostic procedures. The confluence of technological innovations, evolving segmentation strategies, and diverse regional dynamics underscores the importance of a well-calibrated approach to product development and market expansion. By integrating advanced materials, enhancing procedural precision, and adapting to the distinct needs of various healthcare facilities, industry players are perfectly positioned to drive substantial improvement in patient outcomes and clinical efficiency.

The comprehensive analytical framework presented in this summary not only offers a detailed look at the critical segmentation across needle type, procedure, category, material, purchasing channel, application, and end user, but also emphasizes the indispensable regional narratives that influence market behavior. Furthermore, insights drawn from key industry innovators and strategic players provide clarity on competitive dynamics and growth opportunities.

As the market continues to evolve, a steadfast commitment to quality, innovation, and strategic agility remains essential. Industry stakeholders who harness these insights and adopt forward-thinking strategies will be best prepared to navigate the competitive landscape and secure a leadership position in an increasingly dynamic market environment.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing global incidences of cancer and chronic diseases
    • 5.1.1.2. Growing preference for minimally invasive procedures among patients
    • 5.1.1.3. Expanding healthcare infrastructure globally
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulatory approvals and compliance requirements
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing innovation in biodegradable materials for biopsy needles
    • 5.1.3.2. Developing smart biopsy needles capable of real-time tissue analysis to improve diagnostic accuracy
  • 5.1.4. Challenges
    • 5.1.4.1. Consistency issues in product quality
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Increasing adoption of monopty needle for its precision and ease of use
  • 5.2.2. End User: Expanding utilization of biopsy needles in hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biopsy Needles Market, by Type

• 6.1. Introduction
• 6.2. Monopty Needle
• 6.3. Temno Needle

7. Biopsy Needles Market, by Procedure

• 7.1. Introduction
• 7.2. Aspiration Biopsy
• 7.3. Core Biopsy
• 7.4. Vacuum-Assisted Biopsy

8. Biopsy Needles Market, by Category

• 8.1. Introduction
• 8.2. Disposable
• 8.3. Reusable

9. Biopsy Needles Market, by Material

• 9.1. Introduction
• 9.2. Metal
• 9.3. Plastic

10. Biopsy Needles Market, by Purchasing Channel

• 10.1. Introduction
• 10.2. Offline Sales
• 10.3. Online Sales

11. Biopsy Needles Market, by Application

• 11.1. Introduction
• 11.2. Breast Biopsy
• 11.3. Kidney Biopsy
• 11.4. Liver Biopsy
• 11.5. Lung Biopsy
• 11.6. Prostate Biopsy

12. Biopsy Needles Market, by End User

• 12.1. Introduction
• 12.2. Ambulatory Surgical Centers
• 12.3. Diagnostic Clinics
• 12.4. Hospitals

13. Americas Biopsy Needles Market

• 13.1. Introduction
• 13.2. Argentina
• 13.3. Brazil
• 13.4. Canada
• 13.5. Mexico
• 13.6. United States

14. Asia-Pacific Biopsy Needles Market

• 14.1. Introduction
• 14.2. Australia
• 14.3. China
• 14.4. India
• 14.5. Indonesia
• 14.6. Japan
• 14.7. Malaysia
• 14.8. Philippines
• 14.9. Singapore
• 14.10. South Korea
• 14.11. Taiwan
• 14.12. Thailand
• 14.13. Vietnam

15. Europe, Middle East & Africa Biopsy Needles Market

• 15.1. Introduction
• 15.2. Denmark
• 15.3. Egypt
• 15.4. Finland
• 15.5. France
• 15.6. Germany
• 15.7. Israel
• 15.8. Italy
• 15.9. Netherlands
• 15.10. Nigeria
• 15.11. Norway
• 15.12. Poland
• 15.13. Qatar
• 15.14. Russia
• 15.15. Saudi Arabia
• 15.16. South Africa
• 15.17. Spain
• 15.18. Sweden
• 15.19. Switzerland
• 15.20. Turkey
• 15.21. United Arab Emirates
• 15.22. United Kingdom

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Scenario Analysis
  • 16.3.1. Xaga Surgical secures SEK 8 million investment to commercialize innovative biopsy needle technology
  • 16.3.2. Cook Medical introduces EchoTip AcuCore EUS biopsy needle
  • 16.3.3. BIOBOT Surgical secures SGD 24 million Series B funding to advance digital surgery infrastructure
• 16.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Argon Medical Devices, Inc.
• 2. B. Braun SE
• 3. Becton, Dickinson and Company
• 4. Biomedical Srl
• 5. Boston Scientific Corporation
• 6. Cardinal Health, Inc.
• 7. Cook Group Incorporated
• 8. Doctor Japan Co., Ltd.
• 9. Freudenberg Medical, LLC
• 10. Geotek Medical
• 11. Hologic, Inc.
• 12. Inrad, Inc.
• 13. IZI Medical Products
• 14. Medax Srl
• 15. Medi-Tech Devices Pvt. Ltd.
• 16. Medtronic PLC
• 17. Merit Medical Systems, Inc.
• 18. Mermaid Medical Group
• 19. Olympus Corporation
• 20. Pajunk GmbH Medizintechnologie
• 21. Point Blank Medical
• 22. Remington Medical
• 23. Stryker Corporation
• 24. Volkmann MedizinTechnik GmbH
• 25. weLLgo Medical Products GmbH